Kraj: Malta
Język: angielski
Źródło: Medicines Authority
QUETIAPINE
Teva Pharma B.V. Swensweg 5, 2031 GA Haarlem, Netherlands
N05AH04
QUETIAPINE 100 mg
FILM-COATED TABLET
QUETIAPINE 100 mg
POM
PSYCHOLEPTICS
Withdrawn
2011-02-28
1 PACKAGE LEAFLET: INFORMATION FOR THE USERPrzeczytaj cały dokument Quetiapine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What quetiapine is and what it is used for 2. Before you take 3. How to take 4. Possible side effects 5. How to store 6. Further information 1. WHAT QUETIAPINE IS AND WHAT IT IS USED FOR • Quetiapine belongs to a group of medicines called antipsychotics, which help to control the symptoms of a mental illness called schizophrenia. The symptoms include delusions (having strange or unusual thoughts), hallucinations (seeing or hearing things that are not there), experiencing unusual behaviour, which can be aggressive and becoming withdrawn and subdued. • Quetiapine may also be
Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Quetiapine 25, 100, 150, 200, 300 mg Film-coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 25, 100, 150, 200, 300 mg quetiapine (as quetiapine fumarate). Excipients: 25 mg: Each film-coated tablet contains 14 mg of lactose and 0.031 mg of sunset yellow FCF aluminium lake (E110). 100 mg: Each film-coated tablet contains 57 mg of lactose and 0.124 mg of sunset yellow FCF aluminium lake (E110). 150 mg: Each film-coated tablet contains 86 mg of lactose. 200 mg: Each film-coated tablet contains 108 mg of lactose. 300 mg: Each film-coated tablet contains 170 mg of lactose. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. 25 mg: Light-orange, round, biconvex, film-coated tablet, engraved “25” on one side and plain on the other 100 mg: Light-orange, round, biconvex, film-coated tablet, engraved “100” on one side and plain on the other 150 mg: Pale yellow, round, biconvex, film-coated tablet, engraved “150” on one side and plain on the other 200 mg: White to off-white, round, biconvex, film-coated tablet, engraved “200” on one side and plain on the other 300 mg: Pale yellow, capsule-shaped, biconvex, film-coated tablet, engraved “300” on one side and plain on the other 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of schizophrenia. Treatment of moderate to severe manic episode. Quetiapine has not been demonstrated to prevent recurrence of manic or depressive episodes (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Quetiapine should be administered twice daily, with or withou Przeczytaj cały dokument